Allergan Company IP News and Updates

A “catch 22” is defined as a “dilemma or difficult circumstance from which there is no escape because of mutually...

CASE OF THE WEEK BioDelivery Sciences Int’l, Inc. v. Aquestive Therapeutics, Inc., Appeal Nos. 2019-1643, -1644, -1645 (Fed. Cir. Aug....

ALLERGAN SALES, LLC v. SANDOZ, INC. Before Prost, Newman, and Wallach.  Appeal from the United States District Court for the...

In view of the IP hornets’ nest stirred up by Judge Bryson’s ruling in Allergan and the St. Regis Mohawk...

Written by Caleb A. Bates, Ph.D., Peter Law and Eric Furman, Ph.D. Sovereign immunity refers to the doctrine that the government...